Ruhi Mehra: The Evolving Science of Stem Cell Enumeration
Ruhi Mehra, Consultant Transfusion Medicine and Histocompatibility and Immunogenetics at Kokilaben Dhirubhai Ambani Hospital, shared a post on LinkedIn:
“Honored to have served as a panelist at the Mid Term Conference of the Mumbai Hematology Group (MHG) and Essence of EHA-2026 for the session on ‘Stem Cell Enumeration: From Flow Cytometry to Engraftment – Science, Standardization and Clinical Reality.’
This session highlighted the vital, evolving synergy between Transfusion Medicine, Clinical Pathology (Flow cytometry), and Hemato-Oncology.
It is dynamic to see Transfusion Medicine actively integrated into real-time clinical decision-making and patient care strategies.
Grateful to our moderator, Dr. Varsha Vadera Mam, my co-panelist Dr. Kiran Ghodke Sir and Dr. Nishant Jindal Sir and the MHG team for a fantastic discussion!
Grateful to Dr. M. B. Agarwal Sir and Dr. Rucha Patil Mam for the opportunity to be a part of this enriching learning experience!”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events